Christian Herweh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Christian Herweh has a total of 465 co-authors. Here are the top co-authors by number of shared publications:
- Markus Alfred Möhlenbruch
Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany
25 shared publications - Simon Nagel
Department of Neurology (P.A.R., S.N.), Heidelberg University Hospital, Germany
16 shared publications - Martin Bendszus
Abteilung für Neuroradiologie, Universitätsklinikum Heidelberg, Heidelberg, Germany
15 shared publications - Peter Alexander Ringleb
Department of Neurology, Heidelberg University Hospital, Germany
15 shared publications - Johannes Pfaff
Department of Neuroradiology Christian Doppler University Hospital, Paracelsus Medical University Salzburg Austria
14 shared publications Martin Bendszus
Department of Neuroradiology, Heidelberg University, Heidelberg, Germany
14 shared publications
Latest Publications
- Open Access
- 8 October 2026
- Published by BMJ in Journal of NeuroInterventional Surgery
Predictors of treatment failure after middle meningeal artery embolization for chronic subdural hematoma: a German nationwide multicenter study
Introduction Embolization of the middle meningeal artery (EMMA) is an emerging treatment for chronic subdural hematoma (cSDH), yet predictors of treatment failure (TF) remain incompletely characterized. We aimed to identify independent predictors of TF after EMMA for cSDH in a large German nationwide multicenter cohort. Methods In this secondary analysis of a retrospective multicenter study, 569 consecutive patients who underwent 718 EMMA procedures for cSDH across 30 German neurovascular centers (January 2014 to December 2023) were analyzed. TF was defined as residual cSDH >10 mm, hematoma progression, or requirement of rescue surgery. Rescue surgery alone, as well as absolute and relative size reduction, were secondary endpoints. The unit of analysis was the individual embolization procedure. Mixed-effects multivariable logistic regression was performed to identify independent predictors of TF. Results In multivariable analysis, cSDH thickness (adjusted OR (aOR) 1.09, 95% CI 1.05 to 1.13, PConclusion Antithrombotic medication use and greater hematoma thickness were independent predictors of TF after EMMA. These factors may guide individualized treatment selection.
- 8 October 2026
- Published by BMJ in Journal of NeuroInterventional Surgery
Open AccessPredictors of treatment failure after middle meningeal artery embolization for chronic subdural hematoma: a German nationwide multicenter study
Introduction Embolization of the middle meningeal artery (EMMA) is an emerging treatment for chronic subdural hematoma (cSDH), yet predictors of treatment failure (TF) remain incompletely characterized. We aimed to identify independent predictors of TF after EMMA for cSDH in a large German nationwide multicenter cohort. Methods In this secondary analysis of a retrospective multicenter study, 569 consecutive patients who underwent 718 EMMA procedures for cSDH across 30 German neurovascular centers (January 2014 to December 2023) were analyzed. TF was defined as residual cSDH >10 mm, hematoma progression, or requirement of rescue surgery. Rescue surgery alone, as well as absolute and relative size reduction, were secondary endpoints. The unit of analysis was the individual embolization procedure. Mixed-effects multivariable logistic regression was performed to identify independent predictors of TF. Results In multivariable analysis, cSDH thickness (adjusted OR (aOR) 1.09, 95% CI 1.05 to 1.13, PConclusion Antithrombotic medication use and greater hematoma thickness were independent predictors of TF after EMMA. These factors may guide individualized treatment selection.
- Open Access
- 2 September 2026
- Published by Springer Nature in Neuroradiology
- p. 1-10
Clinical outcome after rescue intracranial stenting: a comparison of the ACCLINO flex and the CREDO heal stenting platforms after failed mechanical thrombectomy
Purpose: Mechanical thrombectomy (MT) is the first-line therapy for patients with acute ischemic stroke due to large vessel occlusion; however, despite substantial advances in MT techniques and devices, mechanical recanalization remains unsuccessful in up to 15% of patients. Intracranial rescue stenting represents a promising option to achieve successful recanalization and good clinical outcomes in patients with failed MT. Methods: In this retrospective, observational single-center analysis 77 consecutive patients who underwent failed MT and a maximum of 4 unsuccessful device passes were included. The ACCLINO flex stent / CREDO ® heal stent were used in 38 / 39 patients. The study endpoint was a clinically favorable outcome defined as mRS ≤ 3 at 90 days. Results: A clinically favorable outcome was achieved in 64.1% (25/39) of patients treated with the CREDO heal stent and in 39.5% (15/38) of patients treated with the ACCLINO flex stents ( p = 0.031). Rescue stenting with the CREDO heal stent (aOR 3.51 95% CI 1.11–11.13, p = 0.033), baseline NIHSS (aOR 0.97 95% CI 0.85–0.97, p = 0.005) and pmRS (aOR 0.52 95% CI 0.31–0.89, p = 0.016) were independently associated with a favorable clinical outcome. Baseline characteristics did not differ between both groups. Conclusions: This study suggests that the design of the implanted stent device may influence the clinical outcome. Features such as optimized radial force and thrombogenicity-reducing surfaces of stents used for RIS may improve clinical outcomes of patients treated with intracranial rescue stenting in unsuccessful MT. These findings are hypothesis-generating and require confirmation in prospective, randomized studies.
- 2 September 2026
- Published by Springer Nature in Neuroradiology
- p. 1-10
Open AccessClinical outcome after rescue intracranial stenting: a comparison of the ACCLINO flex and the CREDO heal stenting platforms after failed mechanical thrombectomy
Purpose: Mechanical thrombectomy (MT) is the first-line therapy for patients with acute ischemic stroke due to large vessel occlusion; however, despite substantial advances in MT techniques and devices, mechanical recanalization remains unsuccessful in up to 15% of patients. Intracranial rescue stenting represents a promising option to achieve successful recanalization and good clinical outcomes in patients with failed MT. Methods: In this retrospective, observational single-center analysis 77 consecutive patients who underwent failed MT and a maximum of 4 unsuccessful device passes were included. The ACCLINO flex stent / CREDO ® heal stent were used in 38 / 39 patients. The study endpoint was a clinically favorable outcome defined as mRS ≤ 3 at 90 days. Results: A clinically favorable outcome was achieved in 64.1% (25/39) of patients treated with the CREDO heal stent and in 39.5% (15/38) of patients treated with the ACCLINO flex stents ( p = 0.031). Rescue stenting with the CREDO heal stent (aOR 3.51 95% CI 1.11–11.13, p = 0.033), baseline NIHSS (aOR 0.97 95% CI 0.85–0.97, p = 0.005) and pmRS (aOR 0.52 95% CI 0.31–0.89, p = 0.016) were independently associated with a favorable clinical outcome. Baseline characteristics did not differ between both groups. Conclusions: This study suggests that the design of the implanted stent device may influence the clinical outcome. Features such as optimized radial force and thrombogenicity-reducing surfaces of stents used for RIS may improve clinical outcomes of patients treated with intracranial rescue stenting in unsuccessful MT. These findings are hypothesis-generating and require confirmation in prospective, randomized studies.
- 1 September 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (9) , 2661-2676
Role of Perfusion Parameters on Outcomes and Safety of Endovascular Therapy in Posterior Cerebral Artery Stroke
BACKGROUND: The optimal management of isolated posterior cerebral artery occlusion (iPCAO) remains unclear. We investigated whether baseline perfusion imaging parameters are associated with clinical outcomes and whether they modify the association between endovascular therapy (EVT) and outcomes in iPCAO. METHODS: This prespecified secondary analysis of the international, multicenter, observational PLATO (Posterior Cerebral Artery Occlusion) registry (35 centers, 10 countries, 2015–2025) included consecutive adults with unilateral iPCAO and baseline perfusion imaging (computed tomography or magnetic resonance imaging) with reconstructed parameters. The primary end point was an excellent 90-day outcome (modified Rankin Scale score, 0–1). Perfusion parameters included hypoperfusion volume, infarct core volume, and mismatch ratio. The primary analysis used multivariable mixed-effects regression models (center as random effect) to assess associations between perfusion parameters and outcomes, adjusting for age, sex, treatment year, prestroke modified Rankin Scale score, baseline National Institutes of Health Stroke Scale score, diabetes, stroke cause, posterior circulation Acute Stroke Prognosis Early Computed Tomography Score, occlusion site, intravenous thrombolysis, and onset-to-door time. To test whether the association between EVT and outcomes varies according to baseline perfusion parameters, we evaluated treatment-by-perfusion interactions by including interaction terms (treatment×perfusion parameter) in inverse probability of treatment weighting–adjusted models, with results expressed as ratios of odds ratios (ORs). RESULTS: Of 1811 patients with iPCAO, 443 met inclusion criteria (median age, 74 years; 41.8% female). Larger hypoperfusion volume was associated with lower odds of excellent outcome (adjusted OR, 0.72 [95% CI, 0.58–0.89] per 1-unit increase in natural logarithm–transformed volume). No interaction between perfusion parameters and EVT was observed for the primary outcome. However, increasing core volume was associated with a progressively less favorable modified Rankin Scale score shift (ratio of OR, 0.66 [95% CI, 0.48–0.90]; P interaction =0.009) and higher mortality (ratio of OR, 1.82 [95% CI, 1.10–3.03]; P interaction =0.021) with EVT compared with medical management. Increasing hypoperfusion volume was associated with a higher risk of symptomatic intracranial hemorrhage with EVT (ratio of OR, 10.15 [95% CI, 1.06–96.93]; P interaction =0.044). CONCLUSIONS: In iPCAO, perfusion imaging provides independent prognostic information but does not identify patients with potential benefit from EVT and may instead indicate those at higher procedural risk. REGISTRATION: URL: https://osf.io/62mwt ; Unique identifier: NCT05291637.
- 1 September 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (9) , 2661-2676
Role of Perfusion Parameters on Outcomes and Safety of Endovascular Therapy in Posterior Cerebral Artery Stroke
BACKGROUND: The optimal management of isolated posterior cerebral artery occlusion (iPCAO) remains unclear. We investigated whether baseline perfusion imaging parameters are associated with clinical outcomes and whether they modify the association between endovascular therapy (EVT) and outcomes in iPCAO. METHODS: This prespecified secondary analysis of the international, multicenter, observational PLATO (Posterior Cerebral Artery Occlusion) registry (35 centers, 10 countries, 2015–2025) included consecutive adults with unilateral iPCAO and baseline perfusion imaging (computed tomography or magnetic resonance imaging) with reconstructed parameters. The primary end point was an excellent 90-day outcome (modified Rankin Scale score, 0–1). Perfusion parameters included hypoperfusion volume, infarct core volume, and mismatch ratio. The primary analysis used multivariable mixed-effects regression models (center as random effect) to assess associations between perfusion parameters and outcomes, adjusting for age, sex, treatment year, prestroke modified Rankin Scale score, baseline National Institutes of Health Stroke Scale score, diabetes, stroke cause, posterior circulation Acute Stroke Prognosis Early Computed Tomography Score, occlusion site, intravenous thrombolysis, and onset-to-door time. To test whether the association between EVT and outcomes varies according to baseline perfusion parameters, we evaluated treatment-by-perfusion interactions by including interaction terms (treatment×perfusion parameter) in inverse probability of treatment weighting–adjusted models, with results expressed as ratios of odds ratios (ORs). RESULTS: Of 1811 patients with iPCAO, 443 met inclusion criteria (median age, 74 years; 41.8% female). Larger hypoperfusion volume was associated with lower odds of excellent outcome (adjusted OR, 0.72 [95% CI, 0.58–0.89] per 1-unit increase in natural logarithm–transformed volume). No interaction between perfusion parameters and EVT was observed for the primary outcome. However, increasing core volume was associated with a progressively less favorable modified Rankin Scale score shift (ratio of OR, 0.66 [95% CI, 0.48–0.90]; P interaction =0.009) and higher mortality (ratio of OR, 1.82 [95% CI, 1.10–3.03]; P interaction =0.021) with EVT compared with medical management. Increasing hypoperfusion volume was associated with a higher risk of symptomatic intracranial hemorrhage with EVT (ratio of OR, 10.15 [95% CI, 1.06–96.93]; P interaction =0.044). CONCLUSIONS: In iPCAO, perfusion imaging provides independent prognostic information but does not identify patients with potential benefit from EVT and may instead indicate those at higher procedural risk. REGISTRATION: URL: https://osf.io/62mwt ; Unique identifier: NCT05291637.
- Open Access
- 6 August 2026
- Published by BMJ in Journal of NeuroInterventional Surgery
Copper filtration reduces radiation dose while maintaining image quality in cerebral flat-detector CT
Background: Flat-detector computed tomography (FDCT) is increasingly used for peri-interventional cerebral imaging but is associated with a relatively high radiation exposure. Copper (Cu) filtration may reduce radiation dose. However, its impact on cerebral image quality and intracranial hemorrhage detection remains unclear. Methods: In this retrospective single-center study, 31 patients undergoing neurointerventional procedures with intraindividual FDCT acquisitions with and without Cu filtration were analyzed. Quantitative image quality was assessed using contrast-to-noise ratio (CNR). Qualitative image analysis and intracranial hemorrhage detection were independently evaluated by two readers blinded to Cu filtration status using five-point scales. Results: Cu filtration resulted in a significant radiation dose reduction of 25.9% for both entrance skin dose (145.19±13.18 mGy vs 195.89±18.05 mGy) and dose-area product (41.52±3.77 Gy·cm² vs 56.01±5.16 Gy·cm²), respectively (P<0.001). No differences in CNR were observed for unfiltered vs Cu-filtered FDCT (basal ganglia: 4.73±2.04 vs 4.37±1.99, P=0.419). Qualitative image ratings were similar between techniques (supratentorial cortex: 2.27±0.66 vs 2.08±0.75, P=0.089), with very good inter-reader agreement (κ=0.86; 95% CI: 0.80 to 0.91). All intracranial hemorrhages were correctly identified by both techniques. Correct exclusion of intracranial hemorrhage was 15/16 with Cu filtration and 14/16 without Cu filtration, without statistically significant difference. Differences were limited to hemorrhage mimics (n=2) and minor variations in diagnostic confidence without affecting binary classification. Conclusion: Cu filtration in cerebral FDCT enables substantial radiation dose reduction while preserving image quality and intracranial hemorrhage detection, supporting its clinical implementation as a practical dose optimization strategy for peri-interventional imaging.
- 6 August 2026
- Published by BMJ in Journal of NeuroInterventional Surgery
Open AccessCopper filtration reduces radiation dose while maintaining image quality in cerebral flat-detector CT
Background: Flat-detector computed tomography (FDCT) is increasingly used for peri-interventional cerebral imaging but is associated with a relatively high radiation exposure. Copper (Cu) filtration may reduce radiation dose. However, its impact on cerebral image quality and intracranial hemorrhage detection remains unclear. Methods: In this retrospective single-center study, 31 patients undergoing neurointerventional procedures with intraindividual FDCT acquisitions with and without Cu filtration were analyzed. Quantitative image quality was assessed using contrast-to-noise ratio (CNR). Qualitative image analysis and intracranial hemorrhage detection were independently evaluated by two readers blinded to Cu filtration status using five-point scales. Results: Cu filtration resulted in a significant radiation dose reduction of 25.9% for both entrance skin dose (145.19±13.18 mGy vs 195.89±18.05 mGy) and dose-area product (41.52±3.77 Gy·cm² vs 56.01±5.16 Gy·cm²), respectively (P<0.001). No differences in CNR were observed for unfiltered vs Cu-filtered FDCT (basal ganglia: 4.73±2.04 vs 4.37±1.99, P=0.419). Qualitative image ratings were similar between techniques (supratentorial cortex: 2.27±0.66 vs 2.08±0.75, P=0.089), with very good inter-reader agreement (κ=0.86; 95% CI: 0.80 to 0.91). All intracranial hemorrhages were correctly identified by both techniques. Correct exclusion of intracranial hemorrhage was 15/16 with Cu filtration and 14/16 without Cu filtration, without statistically significant difference. Differences were limited to hemorrhage mimics (n=2) and minor variations in diagnostic confidence without affecting binary classification. Conclusion: Cu filtration in cerebral FDCT enables substantial radiation dose reduction while preserving image quality and intracranial hemorrhage detection, supporting its clinical implementation as a practical dose optimization strategy for peri-interventional imaging.
- Open Access
- 16 June 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (12) , e047192
Large Core Stroke Thrombectomy Is Safe and Effective Regardless of Prior Antithrombotic or Thrombolytic Treatment: A Secondary Analysis of the Randomized TENSION Trial
Background: The relevance of prior antithrombotic and thrombolytic treatment for decision‐making regarding endovascular thrombectomy (EVT) for acute ischemic stroke due to large vessel occlusion with established large infarcts is uncertain. This study investigates associations of prior antithrombotic medication and thrombolysis with the efficacy and safety of EVT for acute ischemic stroke due to large vessel occlusion with established large infarct. Methods: TENSION (Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window) was a prospective randomized open‐label blinded–end point clinical trial. Patients with acute ischemic stroke due to large vessel occlusion and established large infarct were randomized to EVT with medical therapy or medical therapy alone. Exposures were preadmission antithrombotic treatment with antiplatelet agents or anticoagulants and intravenous thrombolysis. The primary efficacy end point was functional outcome at 90 days. Safety outcomes included death and symptomatic intracranial hemorrhage. Results: The study included 246 patients (median age, 74 years; interquartile range, 65 to 80 years; 49% women); 124 (50%) were assigned to EVT. Of 176 patients (72%) with prior antithrombotic therapy, 75 (31%) received antiplatelets, 56 (23%) anticoagulants, and 89 (36%) intravenous thrombolysis. EVT was associated with better functional outcome in patients with (common odds ratio [cOR], 2.40 [95% CI, 1.22–4.99]) and without (cOR, 2.29 [95% CI, 1.53–3.46]) antiplatelet therapy; with (cOR, 2.45 [95% CI, 1.17–5.28]) and without (cOR, 2.12 [95% CI, 1.44–3.15]) anticoagulation; as well as receiving (cOR, 1.46 [95% CI, 0.83–2.61]) and not receiving (cOR, 2.89 [95% CI, 1.87–4.51]) thrombolysis. Interaction analyses were consistent with similar treatment effects across subgroups. Mortality and rates of symptomatic intracranial hemorrhage were similar between groups. Conclusions: Benefit and safety of EVT were not modified by prior antithrombotic/thrombolytic therapy. Preadmission exposure to antiplatelets or anticoagulants or use of intravenous thrombolysis should not exclude eligible patients with stroke from EVT. Registration: URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT03094715.
- 16 June 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (12) , e047192
Open AccessLarge Core Stroke Thrombectomy Is Safe and Effective Regardless of Prior Antithrombotic or Thrombolytic Treatment: A Secondary Analysis of the Randomized TENSION Trial
Background: The relevance of prior antithrombotic and thrombolytic treatment for decision‐making regarding endovascular thrombectomy (EVT) for acute ischemic stroke due to large vessel occlusion with established large infarcts is uncertain. This study investigates associations of prior antithrombotic medication and thrombolysis with the efficacy and safety of EVT for acute ischemic stroke due to large vessel occlusion with established large infarct. Methods: TENSION (Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window) was a prospective randomized open‐label blinded–end point clinical trial. Patients with acute ischemic stroke due to large vessel occlusion and established large infarct were randomized to EVT with medical therapy or medical therapy alone. Exposures were preadmission antithrombotic treatment with antiplatelet agents or anticoagulants and intravenous thrombolysis. The primary efficacy end point was functional outcome at 90 days. Safety outcomes included death and symptomatic intracranial hemorrhage. Results: The study included 246 patients (median age, 74 years; interquartile range, 65 to 80 years; 49% women); 124 (50%) were assigned to EVT. Of 176 patients (72%) with prior antithrombotic therapy, 75 (31%) received antiplatelets, 56 (23%) anticoagulants, and 89 (36%) intravenous thrombolysis. EVT was associated with better functional outcome in patients with (common odds ratio [cOR], 2.40 [95% CI, 1.22–4.99]) and without (cOR, 2.29 [95% CI, 1.53–3.46]) antiplatelet therapy; with (cOR, 2.45 [95% CI, 1.17–5.28]) and without (cOR, 2.12 [95% CI, 1.44–3.15]) anticoagulation; as well as receiving (cOR, 1.46 [95% CI, 0.83–2.61]) and not receiving (cOR, 2.89 [95% CI, 1.87–4.51]) thrombolysis. Interaction analyses were consistent with similar treatment effects across subgroups. Mortality and rates of symptomatic intracranial hemorrhage were similar between groups. Conclusions: Benefit and safety of EVT were not modified by prior antithrombotic/thrombolytic therapy. Preadmission exposure to antiplatelets or anticoagulants or use of intravenous thrombolysis should not exclude eligible patients with stroke from EVT. Registration: URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT03094715.
- Open Access
- 13 May 2026
- Published by Springer Nature in Neuroradiology
- p. 1-9
Sine spin flat-detector CT for enhanced brain parenchyma visualization: an intraindividual comparison on a latest-generation angiography system
Background: Flat-detector computed tomography (FDCT) is increasingly used for periinterventional cerebral imaging. The recently introduced Sine Spin FDCT (S-FDCT) aims to improve cerebral soft tissue contrast compared with conventional FDCT (C-FDCT). Reliable visualization of healthy brain parenchyma is essential for detecting pathological changes. This study compared gray–white matter differentiation between intraindividually acquired S-FDCT and C-FDCT. Methods: A retrospective analysis of a prospectively maintained database included patients with ischemic stroke treated by mechanical thrombectomy who underwent both S-FDCT and C-FDCT within the same interventional session on a latest-generation angiography system. Quantitative image quality was assessed using the contrast-to-noise ratio (CNR). Qualitative image quality was evaluated using a five-point scale at basal ganglia and supratentorial cortex. Analyses focused on healthy brain parenchyma contralateral to infarction. Radiation dose was assessed using entrance-skin dose and dose-area product (DAP). Results: Forty patients (74.2 ± 15.3 years) were analyzed. S-FDCT demonstrated a higher CNR than C-FDCT (mean CNR ± SD: 2.62 ± 1.36 versus 1.03 ± 0.38; p < 0.001). Qualitative ratings were higher for S-FDCT at the basal ganglia (2.45 ± 0.71 versus 1.54 ± 0.53; p < 0.001) and supratentorial cortex (3.01 ± 0.80 versus 1.71 ± 0.60; p < 0.001). Inter-reader agreement was good (κ = 0.798). S-FDCT showed a moderately higher radiation dose than C-FDCT (DAP: 50.6 ± 3.10 versus 46.89 ± 2.86 Gy·cm², p < 0.001). Conclusion: S-FDCT improves cerebral soft tissue visualization compared with C-FDCT in periinterventional imaging. These findings highlight the potential of Sine Spin technology to enhance FDCT image quality and support its role in advanced angiography-suite–based neuroimaging.
- 13 May 2026
- Published by Springer Nature in Neuroradiology
- p. 1-9
Open AccessSine spin flat-detector CT for enhanced brain parenchyma visualization: an intraindividual comparison on a latest-generation angiography system
Background: Flat-detector computed tomography (FDCT) is increasingly used for periinterventional cerebral imaging. The recently introduced Sine Spin FDCT (S-FDCT) aims to improve cerebral soft tissue contrast compared with conventional FDCT (C-FDCT). Reliable visualization of healthy brain parenchyma is essential for detecting pathological changes. This study compared gray–white matter differentiation between intraindividually acquired S-FDCT and C-FDCT. Methods: A retrospective analysis of a prospectively maintained database included patients with ischemic stroke treated by mechanical thrombectomy who underwent both S-FDCT and C-FDCT within the same interventional session on a latest-generation angiography system. Quantitative image quality was assessed using the contrast-to-noise ratio (CNR). Qualitative image quality was evaluated using a five-point scale at basal ganglia and supratentorial cortex. Analyses focused on healthy brain parenchyma contralateral to infarction. Radiation dose was assessed using entrance-skin dose and dose-area product (DAP). Results: Forty patients (74.2 ± 15.3 years) were analyzed. S-FDCT demonstrated a higher CNR than C-FDCT (mean CNR ± SD: 2.62 ± 1.36 versus 1.03 ± 0.38; p < 0.001). Qualitative ratings were higher for S-FDCT at the basal ganglia (2.45 ± 0.71 versus 1.54 ± 0.53; p < 0.001) and supratentorial cortex (3.01 ± 0.80 versus 1.71 ± 0.60; p < 0.001). Inter-reader agreement was good (κ = 0.798). S-FDCT showed a moderately higher radiation dose than C-FDCT (DAP: 50.6 ± 3.10 versus 46.89 ± 2.86 Gy·cm², p < 0.001). Conclusion: S-FDCT improves cerebral soft tissue visualization compared with C-FDCT in periinterventional imaging. These findings highlight the potential of Sine Spin technology to enhance FDCT image quality and support its role in advanced angiography-suite–based neuroimaging.
- 16 February 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (7) , 1838-1845
Bleeding Patterns and Prognostic Implications in Large-Core Ischemic Stroke: Insights from the TENSION Trial
In patients with large-core infarcts, the risk and clinical implications of post-treatment intracranial hemorrhage (ICH) remain poorly understood. We aimed to characterize the frequency, patterns, predictors, and prognostic relevance of post-treatment ICH in patients with large-core infarcts treated in the TENSION trial. We performed a post hoc analysis of 253 patients with anterior circulation stroke and an Alberta Stroke Program Early Computed Tomography Score (ASPECTS) of 3-5 randomized to either mechanical thrombectomy (MT) plus best medical treatment (BMT) or BMT alone. Hemorrhages were categorized both clinically (symptomatic vs. asymptomatic) and radiologically using the Heidelberg Bleeding Classification. Predictors of parenchymal hematoma (PH) and symptomatic ICH (sICH) were identified using logistic regression. The association between bleeding severity and 90-day outcome was evaluated using multivariable models. Any ICH occurred in 45.1% of patients, more frequently after MT compared with BMT (54.4% vs. 35.9%, p=0.004), mostly asymptomatic. Among patients with any ICH, hemorrhagic infarction was associated with the highest rate of favorable outcome (34.0%) and was equally distributed across treatment arms. PH were more common after MT (23.2% vs. 9.4%, p=0.004). Predictors of PH included MT itself (aOR 2.11, CI 1.11-3.99), higher NIHSS (aOR 1.13, CI 1.04-1.23), and larger core volume (aOR 1.003, CI 1.000-1.005). No independent predictors of sICH were identified. In adjusted models, bleeding severity was not associated with poor outcome, whereas age, NIHSS, and core volume were. Importantly, MT remained independently associated with better functional outcomes, even when adjusting for hemorrhagic events. However, the benefit of MT appeared attenuated in patients who developed PH, as shown by a significant treatment interaction. ICH is common in large-core stroke, particularly after MT, but is often asymptomatic and not independently linked to poor outcome. PH may reduce the benefit of MT, but overall, MT remains associated with improved functional outcomes. Distinguishing hemorrhage types is crucial in assessing post-treatment risk in this vulnerable population.
- 16 February 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (7) , 1838-1845
Bleeding Patterns and Prognostic Implications in Large-Core Ischemic Stroke: Insights from the TENSION Trial
In patients with large-core infarcts, the risk and clinical implications of post-treatment intracranial hemorrhage (ICH) remain poorly understood. We aimed to characterize the frequency, patterns, predictors, and prognostic relevance of post-treatment ICH in patients with large-core infarcts treated in the TENSION trial. We performed a post hoc analysis of 253 patients with anterior circulation stroke and an Alberta Stroke Program Early Computed Tomography Score (ASPECTS) of 3-5 randomized to either mechanical thrombectomy (MT) plus best medical treatment (BMT) or BMT alone. Hemorrhages were categorized both clinically (symptomatic vs. asymptomatic) and radiologically using the Heidelberg Bleeding Classification. Predictors of parenchymal hematoma (PH) and symptomatic ICH (sICH) were identified using logistic regression. The association between bleeding severity and 90-day outcome was evaluated using multivariable models. Any ICH occurred in 45.1% of patients, more frequently after MT compared with BMT (54.4% vs. 35.9%, p=0.004), mostly asymptomatic. Among patients with any ICH, hemorrhagic infarction was associated with the highest rate of favorable outcome (34.0%) and was equally distributed across treatment arms. PH were more common after MT (23.2% vs. 9.4%, p=0.004). Predictors of PH included MT itself (aOR 2.11, CI 1.11-3.99), higher NIHSS (aOR 1.13, CI 1.04-1.23), and larger core volume (aOR 1.003, CI 1.000-1.005). No independent predictors of sICH were identified. In adjusted models, bleeding severity was not associated with poor outcome, whereas age, NIHSS, and core volume were. Importantly, MT remained independently associated with better functional outcomes, even when adjusting for hemorrhagic events. However, the benefit of MT appeared attenuated in patients who developed PH, as shown by a significant treatment interaction. ICH is common in large-core stroke, particularly after MT, but is often asymptomatic and not independently linked to poor outcome. PH may reduce the benefit of MT, but overall, MT remains associated with improved functional outcomes. Distinguishing hemorrhage types is crucial in assessing post-treatment risk in this vulnerable population.
- Open Access
- 1 February 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (2) , 362-370
Outcomes of Witnessed Versus Unwitnessed Patients With Stroke After Endovascular Therapy in the Extended Time Window
BACKGROUND: It remains unclear whether outcomes of patients treated with endovascular thrombectomy with large-vessel occlusion and unwitnessed onset of stroke differ from those with witnessed onset in the extended time window. METHODS: We enrolled patients with anterior circulation large-vessel occlusion (internal carotid artery, M1, or M2 segment of the middle cerebral artery) undergoing endovascular thrombectomy within 6 to 24 hours from the time last seen well, from 2014 to 2022, at 66 sites in Europe, North America, and Asia. Patients with a prestroke modified Rankin Scale score of >3 or age P =0.022). Mortality was 21.6% among unwitnessed and 22.0% among witnessed ( P =0.847), and symptomatic intracranial hemorrhage rates were 6.6% and 5.8%, respectively ( P =0.623). The primary outcome (modified Rankin Scale shift) showed no difference comparing unwitnessed to witnessed patients (odds ratio, 1.35 [95% CI, 0.82–2.20]; P =0.235) in the inverse probability of treatment weighting. Unwitnessed patients were more likely to achieve functional independence or return of Rankin (1.53 [1.01–2.33]; P =0.045). Other secondary outcomes did not differ between the witnessed and unwitnessed patients. CONCLUSIONS: In the extended time window, unwitnessed patients with large-vessel occlusion undergoing endovascular thrombectomy have at least the same likelihood of favorable outcomes as witnessed patients. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04096248.
- 1 February 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (2) , 362-370
Open AccessOutcomes of Witnessed Versus Unwitnessed Patients With Stroke After Endovascular Therapy in the Extended Time Window
BACKGROUND: It remains unclear whether outcomes of patients treated with endovascular thrombectomy with large-vessel occlusion and unwitnessed onset of stroke differ from those with witnessed onset in the extended time window. METHODS: We enrolled patients with anterior circulation large-vessel occlusion (internal carotid artery, M1, or M2 segment of the middle cerebral artery) undergoing endovascular thrombectomy within 6 to 24 hours from the time last seen well, from 2014 to 2022, at 66 sites in Europe, North America, and Asia. Patients with a prestroke modified Rankin Scale score of >3 or age P =0.022). Mortality was 21.6% among unwitnessed and 22.0% among witnessed ( P =0.847), and symptomatic intracranial hemorrhage rates were 6.6% and 5.8%, respectively ( P =0.623). The primary outcome (modified Rankin Scale shift) showed no difference comparing unwitnessed to witnessed patients (odds ratio, 1.35 [95% CI, 0.82–2.20]; P =0.235) in the inverse probability of treatment weighting. Unwitnessed patients were more likely to achieve functional independence or return of Rankin (1.53 [1.01–2.33]; P =0.045). Other secondary outcomes did not differ between the witnessed and unwitnessed patients. CONCLUSIONS: In the extended time window, unwitnessed patients with large-vessel occlusion undergoing endovascular thrombectomy have at least the same likelihood of favorable outcomes as witnessed patients. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04096248.
- Open Access
- 10 December 2025
- Published by SAGE Publications in International Journal of Stroke
- Vol. 21 (5) , 646-656
Reperfusion-dependent treatment effects of thrombectomy in patients with large ischemic infarcts
Background: While thrombectomy benefits patients with large infarcts, it is unclear whether this benefit persists across different levels of reperfusion. Aims: This study investigates how the degree of reperfusion influences the effectiveness of endovascular thrombectomy (EVT) combined with best medical treatment (BMT), compared to BMT alone, in patients with large infarcts. Methods: This post hoc analysis of the TENSION trial, a randomized controlled study, assessed EVT versus BMT in patients with extensive infarction (Alberta Stroke Program Early CT Score (ASPECTS) 3–5). Primary outcome was the modified Rankin Scale (mRS) score at 90 days. Secondary outcomes included infarct volume at 24 h, mortality, and symptomatic hemorrhage. Outcomes were stratified by final reperfusion level, measured with the modified thrombolysis in cerebral infarction (mTICI) scale. Confounder-adjusted common odds ratios (cORs) and average treatment effects (ATEs) were estimated using inverse probability weighting with regression adjustment. Results: A total of 246 patients (median age, 74 years (interquartile range (IQR), 65–80); median baseline ASPECTS, 4 (IQR, 3–5)) were included. Compared to BMT alone, unsuccessful EVT (mTICI ⩽ 2a) was not associated with worse functional outcomes (cOR:1.2, 95% CI, 0.95 to 1.52; p = 0.131), higher mortality (ATE: –11.6%; 95% CI, –28.82 to 5.61; p = 0.187), or larger infarct volumes on follow-up (ATE:0.99 mL; 95% CI, –45.30 to 45.32; p = 0.965). First-pass complete reperfusion (mTICI 3) showed the greatest treatment benefit, significantly improving all endpoints, with a cOR of 4.85 (95% CI, 3.74–6.31; p < 0.001) for improved mRS scores and a 29% absolute reduction in mortality. Conclusion: In this post hoc analysis of the TENSION trial, unsuccessful EVT did not worsen outcomes compared to BMT alone. The highest benefit of EVT occurred with first-pass complete reperfusion, emphasizing the importance of achieving optimal reperfusion in this vulnerable stroke subgroup. These findings do not justify general treatment recommendations.
- 10 December 2025
- Published by SAGE Publications in International Journal of Stroke
- Vol. 21 (5) , 646-656
Open AccessReperfusion-dependent treatment effects of thrombectomy in patients with large ischemic infarcts
Background: While thrombectomy benefits patients with large infarcts, it is unclear whether this benefit persists across different levels of reperfusion. Aims: This study investigates how the degree of reperfusion influences the effectiveness of endovascular thrombectomy (EVT) combined with best medical treatment (BMT), compared to BMT alone, in patients with large infarcts. Methods: This post hoc analysis of the TENSION trial, a randomized controlled study, assessed EVT versus BMT in patients with extensive infarction (Alberta Stroke Program Early CT Score (ASPECTS) 3–5). Primary outcome was the modified Rankin Scale (mRS) score at 90 days. Secondary outcomes included infarct volume at 24 h, mortality, and symptomatic hemorrhage. Outcomes were stratified by final reperfusion level, measured with the modified thrombolysis in cerebral infarction (mTICI) scale. Confounder-adjusted common odds ratios (cORs) and average treatment effects (ATEs) were estimated using inverse probability weighting with regression adjustment. Results: A total of 246 patients (median age, 74 years (interquartile range (IQR), 65–80); median baseline ASPECTS, 4 (IQR, 3–5)) were included. Compared to BMT alone, unsuccessful EVT (mTICI ⩽ 2a) was not associated with worse functional outcomes (cOR:1.2, 95% CI, 0.95 to 1.52; p = 0.131), higher mortality (ATE: –11.6%; 95% CI, –28.82 to 5.61; p = 0.187), or larger infarct volumes on follow-up (ATE:0.99 mL; 95% CI, –45.30 to 45.32; p = 0.965). First-pass complete reperfusion (mTICI 3) showed the greatest treatment benefit, significantly improving all endpoints, with a cOR of 4.85 (95% CI, 3.74–6.31; p < 0.001) for improved mRS scores and a 29% absolute reduction in mortality. Conclusion: In this post hoc analysis of the TENSION trial, unsuccessful EVT did not worsen outcomes compared to BMT alone. The highest benefit of EVT occurred with first-pass complete reperfusion, emphasizing the importance of achieving optimal reperfusion in this vulnerable stroke subgroup. These findings do not justify general treatment recommendations.
- 1 May 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (5) , 1116-1127
Thrombectomy With Low ASPECTS: The Roles of Infarct Volume and Postacute Neurological Status
BACKGROUND: Recent randomized trials demonstrated the beneficial effect of endovascular therapy in patients with low Alberta Stroke Program Early CT Score. Despite large follow-up infarct volumes, a significantly increased rate of good functional outcomes was observed, challenging the role of infarct volume as a predictive imaging marker. This analysis evaluates the extent to which the effects of endovascular thrombectomy on functional outcomes are explained by (1) follow-up infarct volume and (2) early neurological status in patients with stroke with low Alberta Stroke Program Early CT Score. METHODS: TENSION (Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window) was a randomized trial conducted from February 2018 to January 2023 across 41 stroke centers. Two hundred fifty-three patients with ischemic stroke due to anterior circulation large vessel occlusion and Alberta Stroke Program Early CT Score of 3 to 5 were randomized to endovascular thrombectomy plus medical treatment or medical treatment alone. All patients with the availability of relevant data points were included in this secondary as-treated analysis. The primary outcome was the 90-day modified Rankin Scale score. Confounder-adjusted mediation analysis was performed to quantify the proportion of the treatment effect on a 90-day modified Rankin Scale score explained by (1) 24-hour follow-up infarct volume and (2) 24-hour National Institutes of Health Stroke Scale scores. RESULTS: One hundred eighty-eight patients were included; thereof, 87 (46%) were female patients. Median age was 72 (interquartile range, 63–79) years. The endovascular thrombectomy cohort had a 20.5 (95% CI, 8.3–33.7) percentage points higher probability of achieving independent ambulation (modified Rankin Scale, 0–3) and a 24.2 (95% CI, 13.4–35.8) percentage points lower mortality at 90 days compared with medical treatment alone. The reduction in 24-hour follow-up infarct volume explained 30% of the treatment effect on functional outcomes, while the 24-hour National Institutes of Health Stroke Scale score explained 61%. CONCLUSIONS: In patients with low Alberta Stroke Program Early CT Score, infarct volume demonstrated limited explanatory power for functional outcomes compared with the early neurological status, which may more effectively reflect factors such as the involvement of specific brain regions, disruption of structural networks, and selective neuronal loss.
- 1 May 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (5) , 1116-1127
Thrombectomy With Low ASPECTS: The Roles of Infarct Volume and Postacute Neurological Status
BACKGROUND: Recent randomized trials demonstrated the beneficial effect of endovascular therapy in patients with low Alberta Stroke Program Early CT Score. Despite large follow-up infarct volumes, a significantly increased rate of good functional outcomes was observed, challenging the role of infarct volume as a predictive imaging marker. This analysis evaluates the extent to which the effects of endovascular thrombectomy on functional outcomes are explained by (1) follow-up infarct volume and (2) early neurological status in patients with stroke with low Alberta Stroke Program Early CT Score. METHODS: TENSION (Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window) was a randomized trial conducted from February 2018 to January 2023 across 41 stroke centers. Two hundred fifty-three patients with ischemic stroke due to anterior circulation large vessel occlusion and Alberta Stroke Program Early CT Score of 3 to 5 were randomized to endovascular thrombectomy plus medical treatment or medical treatment alone. All patients with the availability of relevant data points were included in this secondary as-treated analysis. The primary outcome was the 90-day modified Rankin Scale score. Confounder-adjusted mediation analysis was performed to quantify the proportion of the treatment effect on a 90-day modified Rankin Scale score explained by (1) 24-hour follow-up infarct volume and (2) 24-hour National Institutes of Health Stroke Scale scores. RESULTS: One hundred eighty-eight patients were included; thereof, 87 (46%) were female patients. Median age was 72 (interquartile range, 63–79) years. The endovascular thrombectomy cohort had a 20.5 (95% CI, 8.3–33.7) percentage points higher probability of achieving independent ambulation (modified Rankin Scale, 0–3) and a 24.2 (95% CI, 13.4–35.8) percentage points lower mortality at 90 days compared with medical treatment alone. The reduction in 24-hour follow-up infarct volume explained 30% of the treatment effect on functional outcomes, while the 24-hour National Institutes of Health Stroke Scale score explained 61%. CONCLUSIONS: In patients with low Alberta Stroke Program Early CT Score, infarct volume demonstrated limited explanatory power for functional outcomes compared with the early neurological status, which may more effectively reflect factors such as the involvement of specific brain regions, disruption of structural networks, and selective neuronal loss.